Related Experiment Video
Updated: Jun 3, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
[Multidisciplinary guideline 'Heart failure 2010']
Adriaan A Voors1, Edmond P Walma, T B Twickler
1Universitair Medisch Centrum Groningen, afd. Cardiologie, Groningen, The Netherlands. a.a.voors@thorax.umcg.nl
Insights
This guideline outlines heart failure diagnosis using symptoms, natriuretic peptides, and echocardiography. Treatment involves lifestyle changes, medications like ACE inhibitors, and potentially devices, emphasizing multidisciplinary care.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Practice Guidelines
Context:
- The 'Heart failure 2010' guideline provides a framework for managing heart failure.
- Diagnosis requires clinical assessment, natriuretic peptides, and echocardiography.
- Identifying treatable causes is crucial post-diagnosis.
Purpose:
- To outline the diagnostic criteria for heart failure.
- To detail recommended non-medical and medical treatment strategies.
- To emphasize the importance of coordinated, multidisciplinary patient care.
Summary:
- Heart failure diagnosis combines clinical signs, symptoms, natriuretic peptides, and echocardiography.
- Non-medical treatment prioritizes regular exercise.
- Medical management for systolic heart failure includes diuretics, ACE inhibitors, beta-blockers, and potentially other agents or devices like ICDs.
- Diastolic heart failure treatment has limited evidence.
Impact:
- Facilitates standardized diagnosis and treatment of heart failure.
- Promotes lifestyle modifications, particularly exercise, in heart failure management.
- Highlights the need for integrated care teams to optimize patient outcomes and information delivery.
Abstract:
In the multidisciplinary practice guideline 'Heart failure 2010', the diagnosis of heart failure relies on a combination of signs and symptoms and on supplementary investigation with natriuretic peptides and echocardiography. Once diagnosed, it is important to detect the potentially treatable cause of the heart failure. The non-medical treatment consists of lifestyle advice, of which regular body exercise is the most important component. The medical treatment of patients with systolic heart failure consists of a diuretic, ACE inhibitor, and beta-blocker, optionally extended by an aldosterone antagonist, an angiotensin receptor blocker and/or digoxin. A restricted group of patients may require an internal cardiac defibrillator (ICD) and/or cardiac resynchronisation therapy. There is limited scientific evidence concerning treatment of patients with diastolic heart failure. It is important to coordinate the care of the patient with heart failure within a multidisciplinary team to provide optimal treatment and information for the patient.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Heart Failure III: Clinical Manifestations
